Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick R Appelbaum

Showing results (181-190 of 339) with videos related to

Pageof 34
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2010
Effect of complete remission and responses less than complete remission on survival in acute myeloid leukemia: a combined Eastern Cooperative Oncology Group, Southwest Oncology Group, and M. D. Anderson Cancer Center StudyRoland B Walter, Hagop M Kantarjian, Xuelin Huang, et al.
Leukemia|December 5, 2019
Comparative analysis of total body irradiation (TBI)-based and non-TBI-based myeloablative conditioning for acute myeloid leukemia in remission with or without measurable residual diseaseLinde M Morsink, Evandro D Bezerra, Megan Othus, et al.
Blood|December 7, 2002
Quantitative real-time RT-PCR analysis of PML-RAR alpha mRNA in acute promyelocytic leukemia: assessment of prognostic significance in adult patients from intergroup protocol 0129Robert E Gallagher, Beow Y Yeap, Wanli Bi, et al.
Blood|March 6, 2002
Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in childrenAnn E Woolfrey, Claudio Anasetti, Barry Storer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 16, 2008
Sirolimus in combination with cyclosporine or tacrolimus plus methotrexate for prevention of graft-versus-host disease following hematopoietic cell transplantation from unrelated donorsTerry Furlong, Hans-Peter Kiem, Frederick R Appelbaum, et al.
British Journal of Haematology|August 31, 2006
The clinical spectrum of adult acute myeloid leukaemia associated with core binding factor translocationsFrederick R Appelbaum, Kenneth J Kopecky, Martin S Tallman, et al.
Blood|June 3, 2011
Influence of immunosuppressive treatment on risk of recurrent malignancy after allogeneic hematopoietic cell transplantationYoshihiro Inamoto, Mary E D Flowers, Stephanie J Lee, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 4, 2014
Recommendations for donor human leukocyte antigen assessment and matching for allogeneic stem cell transplantation: consensus opinion of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)C Alan Howard, Marcelo A Fernandez-Vina, Frederick R Appelbaum, et al.
British Journal of Haematology|October 14, 2009
Sequential phase II Southwest Oncology Group studies (S0112 and S0301) of daunorubicin and cytarabine by continuous infusion, without and with ciclosporin, in older patients with previously untreated acute myeloid leukaemiaThomas R Chauncey, Holly Gundacker, Mazyar Shadman, et al.
Leukemia Research|January 24, 2019
The relationship between clinical trial accrual volume and outcomes in acute myeloid leukemia: A SWOG/ECOG-ACRIN study (S0106 and E1900)Bruno C Medeiros, Megan Othus, Martin S Tallman, et al.
Pageof 34

Showing results (181-190 of 339) with videos related to

Sort By:
Pageof 34
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2010
Effect of complete remission and responses less than complete remission on survival in acute myeloid leukemia: a combined Eastern Cooperative Oncology Group, Southwest Oncology Group, and M. D. Anderson Cancer Center StudyRoland B Walter, Hagop M Kantarjian, Xuelin Huang, et al.
Leukemia|December 5, 2019
Comparative analysis of total body irradiation (TBI)-based and non-TBI-based myeloablative conditioning for acute myeloid leukemia in remission with or without measurable residual diseaseLinde M Morsink, Evandro D Bezerra, Megan Othus, et al.
Blood|December 7, 2002
Quantitative real-time RT-PCR analysis of PML-RAR alpha mRNA in acute promyelocytic leukemia: assessment of prognostic significance in adult patients from intergroup protocol 0129Robert E Gallagher, Beow Y Yeap, Wanli Bi, et al.
Blood|March 6, 2002
Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in childrenAnn E Woolfrey, Claudio Anasetti, Barry Storer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 16, 2008
Sirolimus in combination with cyclosporine or tacrolimus plus methotrexate for prevention of graft-versus-host disease following hematopoietic cell transplantation from unrelated donorsTerry Furlong, Hans-Peter Kiem, Frederick R Appelbaum, et al.
British Journal of Haematology|August 31, 2006
The clinical spectrum of adult acute myeloid leukaemia associated with core binding factor translocationsFrederick R Appelbaum, Kenneth J Kopecky, Martin S Tallman, et al.
Blood|June 3, 2011
Influence of immunosuppressive treatment on risk of recurrent malignancy after allogeneic hematopoietic cell transplantationYoshihiro Inamoto, Mary E D Flowers, Stephanie J Lee, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 4, 2014
Recommendations for donor human leukocyte antigen assessment and matching for allogeneic stem cell transplantation: consensus opinion of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)C Alan Howard, Marcelo A Fernandez-Vina, Frederick R Appelbaum, et al.
British Journal of Haematology|October 14, 2009
Sequential phase II Southwest Oncology Group studies (S0112 and S0301) of daunorubicin and cytarabine by continuous infusion, without and with ciclosporin, in older patients with previously untreated acute myeloid leukaemiaThomas R Chauncey, Holly Gundacker, Mazyar Shadman, et al.
Leukemia Research|January 24, 2019
The relationship between clinical trial accrual volume and outcomes in acute myeloid leukemia: A SWOG/ECOG-ACRIN study (S0106 and E1900)Bruno C Medeiros, Megan Othus, Martin S Tallman, et al.
Pageof 34